NYSE - Nasdaq Real Time Price USD
Johnson & Johnson (JNJ)
154.10
-1.28
(-0.82%)
As of 1:54:09 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 509,674 | 21 |
| Sales | 20,417 | 3 |
| Net Shares Purchased (Sold) | 489,257 | 24 |
| Total Insider Shares Held | 1.35M | -- |
| % Net Shares Purchased (Sold) | 56.50% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| DUATO JOAQUIN BOIX Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Mar 18, 2025 |
| DECKER ROBERT J Officer | Sale at price 165.88 per share. | Direct | 1,160,994 | Feb 25, 2025 |
| DECKER ROBERT J Officer | Conversion of Exercise of derivative security at price 101.87 per share. | Direct | 712,988 | Feb 25, 2025 |
| SCHMID TIMOTHY Officer | Sale at price 156.15 per share. | Direct | 62,928 | Feb 18, 2025 |
| FORMINARD ELIZABETH General Counsel | -- | Direct | -- | Feb 14, 2025 |
| SCHMID TIMOTHY Officer | -- | Direct | -- | Feb 14, 2025 |
| SCHMID TIMOTHY Officer | -- | Direct | -- | Feb 14, 2025 |
| MULHOLLAND KRISTEN Officer | -- | Direct | -- | Feb 14, 2025 |
| BROADHURST VANESSA Officer | -- | Direct | -- | Feb 14, 2025 |
| DECKER ROBERT J Officer | -- | Direct | -- | Feb 14, 2025 |
| SWANSON JAMES D Chief Technology Officer | -- | Direct | -- | Feb 14, 2025 |
| REED JOHN C Officer | -- | Direct | -- | Feb 14, 2025 |
| TAUBERT JENNIFER L Officer | -- | Direct | -- | Feb 14, 2025 |
| WOLK JOSEPH J Chief Financial Officer | -- | Direct | -- | Feb 14, 2025 |
| WENGEL KATHRYN E Chief Technology Officer | -- | Direct | -- | Feb 14, 2025 |
| DUATO JOAQUIN BOIX Chief Executive Officer | -- | Direct | -- | Feb 14, 2025 |
| WOLK JOSEPH J Chief Financial Officer | Sale at price 153.89 per share. | Direct | 2,002,878 | Feb 7, 2025 |
| TAUBERT JENNIFER L Officer | Conversion of Exercise of derivative security at price 100.06 per share. | Direct | 5,853,910 | Feb 7, 2025 |
| WOLK JOSEPH J Chief Financial Officer | Conversion of Exercise of derivative security at price 100.06 per share. | Direct | 1,302,281 | Feb 7, 2025 |
| WENGEL KATHRYN E Chief Operating Officer | Conversion of Exercise of derivative security at price 100.06 per share. | Direct | 3,278,166 | Feb 7, 2025 |
| DUATO JOAQUIN BOIX Chief Executive Officer | Conversion of Exercise of derivative security at price 100.06 per share. | Direct | 12,644,482 | Feb 7, 2025 |
| WEINBERGER MARK A Director | Purchase at price 147.22 per share. | Direct | 147,220 | Dec 12, 2024 |
| WOLK JOSEPH J Chief Financial Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Oct 17, 2024 |
| DECKER ROBERT J Officer | Sale at price 165.06 per share. | Direct | 930,113 | Aug 30, 2024 |
| DECKER ROBERT J Officer | Conversion of Exercise of derivative security at price 100.06 per share. | Direct | 563,838 | Aug 30, 2024 |
| BROADHURST VANESSA Officer | -- | Direct | -- | Jul 8, 2024 |
| REED JOHN C Officer | -- | Direct | -- | May 1, 2024 |
| REED JOHN C Officer | -- | Direct | -- | May 1, 2024 |
| WOODS EUGENE A Director | Purchase at price 145.53 per share. | Indirect | 14,553 | Apr 30, 2024 |
| BROADHURST VANESSA Officer | Sale at price 162.16 per share. | Direct | 1,441,765 | Mar 13, 2024 |
| FORMINARD ELIZABETH General Counsel | -- | Direct | -- | Feb 13, 2024 |
| SCHMID TIMOTHY Officer | -- | Direct | -- | Feb 13, 2024 |
| HAIT WILLIAM Officer | -- | Direct | -- | Feb 13, 2024 |
| BROADHURST VANESSA Officer | -- | Direct | -- | Feb 13, 2024 |
| DECKER ROBERT J Officer | -- | Direct | -- | Feb 13, 2024 |
| SWANSON JAMES D Chief Technology Officer | -- | Direct | -- | Feb 13, 2024 |
| FASOLO PETER M Officer | -- | Direct | -- | Feb 13, 2024 |
| TAUBERT JENNIFER L Officer | -- | Direct | -- | Feb 13, 2024 |
| WOLK JOSEPH J Chief Financial Officer | -- | Direct | -- | Feb 13, 2024 |
| WENGEL KATHRYN E Officer | -- | Direct | -- | Feb 13, 2024 |
| DUATO JOAQUIN BOIX Chief Executive Officer | -- | Direct | -- | Feb 13, 2024 |
| BROADHURST VANESSA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| FORMINARD ELIZABETH General Counsel | -- | Direct | -- | Feb 12, 2024 |
| SCHMID TIMOTHY Officer | -- | Direct | -- | Feb 12, 2024 |
| HAIT WILLIAM Officer | -- | Direct | -- | Feb 12, 2024 |
| BROADHURST VANESSA Officer | -- | Direct | -- | Feb 12, 2024 |
| DECKER ROBERT J Officer | -- | Direct | -- | Feb 12, 2024 |
| SWANSON JAMES D Chief Technology Officer | -- | Direct | -- | Feb 12, 2024 |
| FASOLO PETER M Officer | -- | Direct | -- | Feb 12, 2024 |
| TAUBERT JENNIFER L Officer | -- | Direct | -- | Feb 12, 2024 |
Related Tickers
MRK Merck & Co., Inc.
78.79
+0.06%
PFE Pfizer Inc.
22.75
+1.59%
ABBV AbbVie Inc.
180.03
+1.68%
BMY Bristol-Myers Squibb Company
48.37
-0.34%
AMGN Amgen Inc.
278.62
+0.26%
LLY Eli Lilly and Company
857.94
+3.44%
NVO Novo Nordisk A/S
62.65
+2.20%
GILD Gilead Sciences, Inc.
106.08
-0.29%
AZN AstraZeneca PLC
69.34
+1.21%
GSK GSK plc
37.37
+0.90%